Israeli biotech Keystone Heart’s TriGuard is a cerebral protection device specifically designed to minimize the risk of brain damage during heart valve replacements and other cardiovascular procedures. Keystone has just raised $14 million of investment funding.
http://www.globes.co.il/en/article-cerebral-protection-co-keystone-heart-raises-14m-1000939820